The Mode of Action
The Mechanisms of Action
PREVYMIS® was approved for prophylaxis of CMV reactivation and disease in adult CMV R+ allogeneic HSCT recipients
This illustration has been produced by MSD based on Foolad, et al., 2018
References:
- Marty FM et al., Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation. N Engl J Med. 2017 Dec 21;377(25):2433-2444. doi: 10.1056/NEJMoa1706640. Epub 2017 Dec 6. PMID: 29211658.
